Cheran Elangovan

Cheran Elangovan, MD, is an Assistant Professor at the University of Tennessee Health Science Center's College of Medicine – Memphis, Department of Neurology. He is dual-certified in Neurology and Vascular Neurology, with clinical expertise in stroke management, anticoagulation therapy, and mechanical thrombectomy. His research focuses on stroke prevention, recurrence analysis, and telemedicine applications in neurology.

• MD/MBBS, Government Stanley Medical College (2014)
• Fellowship, Vascular Neurology, University of Tennessee Health Science Center (2020–2021)
• Residency, Neurology, Penn State College of Medicine (2017–2020)
• Internship, Internal Medicine, Penn State College of Medicine (2016–2017)

His recent work explores stroke recurrence after cervical artery dissection, antithrombotic strategies for embolic stroke of undetermined source (ESUS), and machine learning applications in predicting intracranial hemorrhage post-thrombectomy. Collaborative studies include the STOP-CAD and CASPR registries, emphasizing diagnostic accuracy and treatment optimization.

Key trends in his publications include comparative analyses of anticoagulation vs. antiplatelet therapy for stroke prevention, telestroke care models, malignancy-stroke associations, and pharmacological outcomes. Sub-fields span ESUS, vascular imaging, thrombectomy protocols, and neurovascular emergencies.

Dr. Elangovan contributes to clinical education through peer review acknowledgment in Academic Medicine and Neurology journals. His affiliations include the CASPR and STOP-CAD studies, focusing on evidence-based stroke care and risk stratification.